AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ...

Sir Pascal Soriot is usually steps ahead of the game, so always worth listening to. His latest red flag is that Europe is ...

AstraZeneca CEO Pascal Soriot joins Morning Brief to discuss the outlook for the company and outlines AstraZeneca's plans to ...

AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.

So that would be a huge incentive to also bring manufacturing here," Bourla said. His comments mirror those of AstraZeneca ...

Discover AstraZeneca's Q1 2025 performance with 10% revenue growth, innovative medicines, and bold 2030 goals.

Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro ...

AstraZeneca has warned that countries must buy more of its cutting-edge medicines or jobs and investment will shift abroad.

"Our company is firmly committed to investing and growing in the US," chief executive Pascal Soriot said in an earnings ...

The chief executive of the Cambridge-headquartered pharmaceutical giant AstraZeneca has urged the European Union to allow the ...